Share on Facebook Share on Twitter Email
Answers.com

Dexfenfluramine

 
Wikipedia: Dexfenfluramine
Dexfenfluramine
Systematic (IUPAC) name
(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]-propan-2-amine
Identifiers
CAS number 3239-44-9
ATC code A08AA04
PubChem 66265
DrugBank APRD00648
ChemSpider 59646
Chemical data
Formula C12H16F3N 
Mol. mass 231.257 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Protein binding 36%
Metabolism  ?
Half life 17-20 hours
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

Schedule IV(US) Withdrawn from market

Routes  ?
 Yes check.svgY(what is this?)  (verify)

Dexfenfluramine, also marketed under the name Redux, is a serotoninergic anorectic drug. It was for some years in the mid-1990s approved by the United States Food and Drug Administration for the purposes of weight loss. However, following multiple concerns about the cardiovascular side-effects of the drug, such approval was withdrawn. After it was removed in the US, dexfenfluramine was also pulled out in other global markets. It was later superseded by sibutramine, which is a safer alternative to both dexfenfluramine and fenfluramine.

The drug was manufactured by Interneuron Pharmaceuticals and marketed by Wyeth-Ayerst Laboratories. It is the enantiomer of levofenfluramine.

See also

References



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Shopping: Dexfenfluramine
Top
 
 
Learn More
Dexfenfluramine
Redux (trademark)
Dexfenfluramine capsules

Post a question - any question - to the WikiAnswers community:

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Dexfenfluramine" Read more